Review



high sensitivity cytokine premixed bead kit a  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems high sensitivity cytokine premixed bead kit a
    Plasma <t>cytokine</t> levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    High Sensitivity Cytokine Premixed Bead Kit A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/high+sensitivity+cytokine+premixed+bead+kit+a/Human+High+Sensitivity+Cytokine+A+Premixed+Magnetic+Luminex%C2%AE+Performance+Assay/pmc11189388-249-16-23
    Average 93 stars, based on 26 article reviews
    high sensitivity cytokine premixed bead kit a - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms"

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms

    Journal: Nature Communications

    doi: 10.1038/s41467-024-49041-2

    Plasma cytokine levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    Figure Legend Snippet: Plasma cytokine levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.

    Techniques Used: Clinical Proteomics, Multiplex Assay, Infection, Concentration Assay, Comparison, Real-time Polymerase Chain Reaction

    Related Articles

    Clinical Proteomics:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.

    Multiplex Assay:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.

    Infection:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.

    Concentration Assay:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.

    Comparison:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.

    Real-time Polymerase Chain Reaction:

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms
    Article Snippet: Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.Magnetic Luminex Performance Assay Plasma cytokines were analyzed for each volunteer on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx + 7) for each CHMI.. IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.. All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.All samples were centrifugated at 16,000 × g for 4 min before use and diluted 2-fold with calibrator diluent RD6-40.



    Similar Products

    high sensitivity cytokine premixed bead kit a  (R&D Systems)
    93
    R&D Systems high sensitivity cytokine premixed bead kit a
    Plasma <t>cytokine</t> levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    High Sensitivity Cytokine Premixed Bead Kit A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/high+sensitivity+cytokine+premixed+bead+kit+a/Human+High+Sensitivity+Cytokine+A+Premixed+Magnetic+Luminex%C2%AE+Performance+Assay/pmc11189388-249-16-23
    Average 93 stars, based on 1 article reviews
    high sensitivity cytokine premixed bead kit a - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    human high sensitivity cytokine a premixed magnetic luminex® performance assay  (Bio-Techne corporation)
    93
    Bio-Techne corporation human high sensitivity cytokine a premixed magnetic luminex® performance assay
    Plasma <t>cytokine</t> levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    Human High Sensitivity Cytokine A Premixed Magnetic Luminex® Performance Assay, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/high+sensitivity+cytokine+premixed+bead+kit+a/Human+High+Sensitivity+Cytokine+A+Premixed+Magnetic+Luminex%C2%AE+Performance+Assay/bio-techne+corporation___fcstm09
    Average 93 stars, based on 1 article reviews
    human high sensitivity cytokine a premixed magnetic luminex® performance assay - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    milliplex map high sensitivity human cytokine premixed magnetic bead kit  (Millipore)
    90
    Millipore milliplex map high sensitivity human cytokine premixed magnetic bead kit
    Plasma <t>cytokine</t> levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    Milliplex Map High Sensitivity Human Cytokine Premixed Magnetic Bead Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/high+sensitivity+cytokine+premixed+bead+kit+a/milliplex/pmc09868004-219-11-21
    Average 90 stars, based on 1 article reviews
    milliplex map high sensitivity human cytokine premixed magnetic bead kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    magnetic beads-based kit milliplex map high sensitivity human cytokine panel – premixed 13 plex  (Millipore)
    90
    Millipore magnetic beads-based kit milliplex map high sensitivity human cytokine panel – premixed 13 plex
    Plasma <t>cytokine</t> levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.
    Magnetic Beads Based Kit Milliplex Map High Sensitivity Human Cytokine Panel – Premixed 13 Plex, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/high+sensitivity+cytokine+premixed+bead+kit+a/magnetic+beads+based+kit+milliplex+map+high+sensitivity+human+cytokine+panel+++premixed+13+plex/pmc03871963-115-55-56
    Average 90 stars, based on 1 article reviews
    magnetic beads-based kit milliplex map high sensitivity human cytokine panel – premixed 13 plex - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Plasma cytokine levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.

    Journal: Nature Communications

    Article Title: Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms

    doi: 10.1038/s41467-024-49041-2

    Figure Lengend Snippet: Plasma cytokine levels were measured by multiplex bead analysis for each participant (CHMI 1 n = 8, CHMI 2 n = 8, CHMI 3 n = 8, CHMI 4 n = 5) on D1 before exposure to Pf-infected mosquitoes, D6, D8, day of treatment (DRx) and 7 days after treatment (DRx+7) for each CHMI. A The heatmap of the log of the average ratio of the cytokine concentration (pg/ml) on the indicated day of the CHMI to the baseline concentration following the mock challenge for all participants is shown. B Comparison of the parasitemia (parasites/ml) measured by quantitative PCR (qPCR) of Pf18s rRNA, the ratio of the plasma cytokine levels to the mock CHMI baseline quantified using a multiplex bead assay, and maximal temperature (°C) measured on the day each participant experienced their first and second peak of >3.3 parasites/µl ( n = 6). Data are presented as mean values +/− standard error of the mean (SEM). Statistical differences were tested using Sidak’s multiple comparisons test and the P value is two-sided. Source data are provided as a file.

    Article Snippet: IFNγ, IL-10, IL-6, TNF alpha, IL-8, IL-12, IL-1 beta, IL-4 levels were measured using the human high sensitivity cytokine premixed bead kit A (R&D Systems), while standard premixed bead kits (R&D Systems) were used for the rest.

    Techniques: Clinical Proteomics, Multiplex Assay, Infection, Concentration Assay, Comparison, Real-time Polymerase Chain Reaction